retatrutide mechanism glp-1 gip glucagon triple agonist review 2024 2025 What You Need to Know About Retatrutide: is a new “triple agonist” medication that targets three hormone receptors—GLP-1, GIP, and glucagon. These hormones regulate appetite, energy use, and glucose metabolism. By What GLP‑3 Really Is: Retatrutide
Pay in 4 interest-free payments of $6.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14








:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)






:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)



![Tirzepatide vs. Semaglutide: Which Weight Loss Drug Works Better? [May 2025 NEJM Study Explained]](https://belite.com/wp-content/uploads/2025/06/July-2025-Blog-Post-Belite.png)




